08:00 , Feb 4, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: ATPase H+/K+ transporting nongastric α polypeptide (ATP12A)

Infectious disease INDICATION: Staphylococcus Patient sample, cell culture and pig studies suggest inhibiting ATP12A could help treat Staphylococcus aureus infection in cystic fibrosis (CF) patients. In S. aureus-infected airway epithelial cells from CF patients and...